HOME › DRUGS › RIFAMPIN
ACTIVE SUBSTANCE / INN

RIFAMPIN

Brand name(s): RIFADIN, RIFAMPIN AND ISONIAZID, RIMACTANE, RIFAMATE, RIFATER, RIFAMPIN
FDA LISTED
PRESCRIPTION
DISCONTINUED
ANDA206736
ANDA061884
ACTIVE SUBSTANCE
Rifampin
REGULATORS
FDA
SPONSORS / MAH
HIKMA INTL PHARMS, WATSON PHARMS TEVA, OXFORD PHARMS
TOTAL APPLICATIONS
8
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
RIFAMPINANDA206736WATSON PHARMS TEVADiscontinued
RIFAMPINANDA064217HIKMAPrescription
RIMACTANENDA050429OXFORD PHARMSPrescription
RIFAMPIN AND ISONIAZIDANDA065221HIKMA INTL PHARMSDiscontinued
RIFADINNDA050420SANOFI AVENTIS USDiscontinued
RIFADINNDA050627SANOFI AVENTIS USPrescription
RIFAMATEANDA061884SANOFI AVENTIS USDiscontinued
RIFATERNDA050705SANOFI AVENTIS USDiscontinued

FULL INTELLIGENCE ON RIFAMPIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →